Markus Schiller

410 total citations
10 papers, 326 citations indexed

About

Markus Schiller is a scholar working on Computational Theory and Mathematics, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Markus Schiller has authored 10 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Computational Theory and Mathematics, 2 papers in Organic Chemistry and 2 papers in Molecular Biology. Recurrent topics in Markus Schiller's work include Computational Drug Discovery Methods (4 papers), Cholinesterase and Neurodegenerative Diseases (2 papers) and Nicotinic Acetylcholine Receptors Study (2 papers). Markus Schiller is often cited by papers focused on Computational Drug Discovery Methods (4 papers), Cholinesterase and Neurodegenerative Diseases (2 papers) and Nicotinic Acetylcholine Receptors Study (2 papers). Markus Schiller collaborates with scholars based in Germany, United States and Italy. Markus Schiller's co-authors include Tanja Schirmeister, Knut Baumann, Andreas K. Buck, Samuel Samnick, John Ziebuhr, Nikolaus Stiefl, Radim Vičík, Bernd Engels, Michael Laßmann and Michael Flentje and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecules and The Analyst.

In The Last Decade

Markus Schiller

9 papers receiving 320 citations

Peers

Countries citing papers authored by Markus Schiller

Since Specialization

Citations

This map shows the geographic impact of Markus Schiller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Schiller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Schiller more than expected).

Fields of papers citing papers by Markus Schiller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Schiller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Schiller. The network helps show where Markus Schiller may publish in the future.

Co-authorship network of co-authors of Markus Schiller

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Schiller. A scholar is included among the top collaborators of Markus Schiller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Schiller. Markus Schiller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Nordkoreas Raketenprogramm – Bedrohung oder Bluff? 2017 ·SIRIUS - Zeitschrift für Strategische Analysen ·(unknown), Markus Schiller	1
2	Nicotinic Acetylcholine Receptor Density in Cognitively Intact Subjects at an Early Stage of Parkinsonâ€™s Disease 2014 ·Frontiers in Aging Neuroscience ·Ioannis U. Isaias, (unknown), Joachim Brumberg, Kelly Cosgrove, Giorgio Marotta, Naoya Oishi, Takahiro Higuchi, (unknown), Markus Schiller, Ulrich Dillmann, Christopher H. van Dyck, Andreas K. Buck, Ken Herrmann, (unknown), Jens Volkmann, Michael Laßmann, Klaus Faßbender, R. Lorenz, Samuel Samnick	23
3	Nicotinicα₄β₂acetylcholine receptors and cognitive function in Parkinson's disease 2014 ·Acta Neurologica Scandinavica ·R. Lorenz, Samuel Samnick, Ulrich Dillmann, Markus Schiller, M.F. Ong, Klaus Faßbender, Andreas K. Buck, Jörg Spiegel	23
4	Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma 2012 ·Radiation Oncology ·Michael C. Kreißl, Heribert Hänscheid, Mario Löhr, Frederik A. Verburg, Markus Schiller, Michael Laßmann, Christoph Reiners, Samuel Samnick, Andreas K. Buck, Michael Flentje, Reinhart A. Sweeney	72
5	Quantitative detection of C-deuterated drugs by CARS microscopy and Raman microspectroscopy 2011 ·The Analyst ·(unknown), (unknown), Markus Schiller, Gerhard Bringmann, Tanja Schirmeister, Benjamin Dietzek, Stephan Niebling, Sebastian Schlücker, Jürgen Popp	42
6	Enzyme Kinetics and Hit Validation in Fluorimetric Protease Assays 2010 ·Current Topics in Medicinal Chemistry ·(unknown), (unknown), Markus Schiller, Knut Baumann, Tanja Schirmeister	36
7	Mechanistic Study of the Reaction of Thiol‐Containing Enzymes with α,β‐Unsaturated Carbonyl Substrates by Computation and Chemoassays 2010 ·ChemMedChem ·(unknown), Markus Schiller, Tanja Schirmeister, Bernd Engels	31
8	Synthesis and Evaluation of Non-peptidic Cysteine Protease Inhibitors of P. falciparum Derived from Etacrynic Acid 2008 ·Molecules ·(unknown), (unknown), (unknown), Markus Schiller, F. A. Schulz, (unknown), (unknown), Gabriele Pradel, Jiří Gut, Philip J. Rosenthal, Tanja Schirmeister, Matthias Leippe, Christoph Gelhaus	8
9	Screening of electrophilic compounds yields an aziridinyl peptide as new active-site directed SARS-CoV main protease inhibitor 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Nikolaus Stiefl, (unknown), F. A. Schulz, (unknown), Markus Schiller, Radim Vičík, Knut Baumann, John Ziebuhr, Tanja Schirmeister	38
10	A New Lead for Nonpeptidic Active-Site-Directed Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus Main Protease Discovered by a Combination of Screening and Docking Methods 2005 ·Journal of Medicinal Chemistry ·(unknown), Nikolaus Stiefl, Markus Schiller, Radim Vičík, (unknown), Werner Schmitz, (unknown), Carsten Schmuck, Knut Baumann, John Ziebuhr, Tanja Schirmeister	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact